Breaking News Instant updates and real-time market news.

STJ

Acquired by ABT

$78.06

0.08 (0.10%)

13:01
10/17/16
10/17
13:01
10/17/16
13:01

St. Jude Medical to form cyber security medical advisory board

St. Jude Medical announced that it is forming a Cyber Security Medical Advisory Board, or CSMAB, to advise as it continues to advance cyber security standards in the medical device industry by working with experts and government agencies. "We recognize that improving technology to address cyber security risks must be balanced with how to best care for patients benefitting from medical devices. Creating the CSMAB ensures we receive direct feedback from leading physicians on patient management considerations. St. Jude Medical's ongoing commitment is to ensure our medical device ecosystem always puts patient safety at the forefront...Establishing the CSMAB will help ensure that St. Jude Medical's cyber security protections continue to be innovative and meet the demands of the dynamic cyber security environment without jeopardizing patient care. Patient care is, and has always been, our top priority," the company stated.

  • 19

    Oct

  • 26

    Oct

STJ Acquired by ABT
$78.06

0.08 (0.10%)

08/29/16
FBCO
08/29/16
NO CHANGE
FBCO
St. Jude Medical can fix security deficiencies, says Credit Suisse
After speaking with "a developer of software used in drugs/devices" about Muddy Waters' security concerns regarding St. Jude's CRM system, Credit Suisse analyst Matthew Keeler says the consultant believes that the security deficiencies,can be fixed. According to the consultant, the deficiencies can be fixed using a five to ten person team working for about three months, Keeler stated. Keeler does not think that St. Jude's pending acquisition by Abbott (ABT) will be impacted by Muddy Waters' report. He keeps an $81 price target and Neutral rating on St. Jude.
09/08/16
PIPR
09/08/16
NO CHANGE
Target $82
PIPR
Neutral
Piper sees little reason to believe St. Jude deal will not close
Piper Jaffray analyst Brooks West says cybersecurity expert Mark Lanterman during a conference call yesterday refuted security claims by MedSec and Muddy Waters against St. Jude Medical's (STJ) pacemakers, defibrillators and Merlin monitoring system. Lanterman stated that there is "not much meat on the bone" to the MedSec claims and the quality of the analysis, West tells investors in a research note. He notes that Abbott (ABT) yesterday at a competitor conference earlier stated the St. Jude acquisition was progressing toward a close before year-end. The analyst sees little reason to believe the transaction will not close in the planned timeframe. West reiterates a Neutral rating on St. Jude.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

GNC

GNC Holdings

$3.47

0.02 (0.58%)

07:06
01/18/18
01/18
07:06
01/18/18
07:06
Earnings
GNC Holdings sees Q4 adjusted EPS 24c-25c, consensus 23c »

GNC Holdings reported an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBSH

Commerce Bancshares

$58.16

0.365 (0.63%)

07:05
01/18/18
01/18
07:05
01/18/18
07:05
Earnings
Commerce Bancshares reports Q4 EPS 86c, consensus 72c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$55.35

0.75 (1.37%)

07:05
01/18/18
01/18
07:05
01/18/18
07:05
Hot Stocks
Morgan Stanley reports Q4 annualized return on average common equity of 2.9% »

The annualized return on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

IPHI

Inphi

$37.87

0.01 (0.03%)

07:05
01/18/18
01/18
07:05
01/18/18
07:05
Hot Stocks
Inphi sees Q1 remaining 'challenging' due to ongoing China slowdown »

Ahead of today's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

SMTS

Sierra Metals

$2.62

0.02 (0.77%)

07:04
01/18/18
01/18
07:04
01/18/18
07:04
Hot Stocks
Sierra Metals reports 2017 and 4Q17 production »

Sierra Metals reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$55.35

0.75 (1.37%)

07:04
01/18/18
01/18
07:04
01/18/18
07:04
Earnings
Morgan Stanley reports Q4 adjusted EPS 84c, consensus 77c »

Excluding net discrete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

CSII

Cardiovascular Systems

$26.24

0.91 (3.59%)

07:02
01/18/18
01/18
07:02
01/18/18
07:02
Hot Stocks
Cardiovascular Systems partners with OrbusNeich, forms OEM agreement »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

SPX

S&P 500

07:02
01/18/18
01/18
07:02
01/18/18
07:02
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGEN

Compugen

$2.75

0.25 (10.00%)

07:02
01/18/18
01/18
07:02
01/18/18
07:02
Hot Stocks
Compugen presents new data demonstrating features of the PVRIG pathway »

Compugen announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.27

0.68 (1.37%)

, PANW

Palo Alto Networks

$154.23

2.63 (1.73%)

07:01
01/18/18
01/18
07:01
01/18/18
07:01
Recommendations
Oracle, Palo Alto Networks, Apptio, Alarm.com, Nice, Symantec, RingCentral, Splunk, VMware analyst commentary  »

Jefferies sees more…

ORCL

Oracle

$50.27

0.68 (1.37%)

PANW

Palo Alto Networks

$154.23

2.63 (1.73%)

APTI

Apptio

$24.00

0.29 (1.22%)

ALRM

Alarm.com

$38.27

1.26 (3.40%)

NICE

Nice

$92.63

0.67 (0.73%)

SYMC

Symantec

$27.52

-0.35 (-1.26%)

RNG

RingCentral

$51.50

0.85 (1.68%)

SPLK

Splunk

$90.57

3.44 (3.95%)

VMW

VMware

$135.33

3.19 (2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 31

    Jan

  • 05

    Feb

  • 26

    Feb

  • 27

    Feb

AES

AES Corp.

$10.72

0.04 (0.37%)

07:01
01/18/18
01/18
07:01
01/18/18
07:01
Hot Stocks
AES Corp. names ValueAct CEO Jeffrey Ubben to board »

The AES Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$160.21

2.25 (1.42%)

07:00
01/18/18
01/18
07:00
01/18/18
07:00
Hot Stocks
Accenture awarded $62M contract with Veterans Benefits Administration »

Accenture has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$55.35

0.75 (1.37%)

06:59
01/18/18
01/18
06:59
01/18/18
06:59
Hot Stocks
Morgan Stanley reports Common Equity Tier 1 ratio approximately 16.5% »

As of December 31, 2017,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

GDX

Market Vector Gold Miners

$23.94

-0.43 (-1.76%)

06:58
01/18/18
01/18
06:58
01/18/18
06:58
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$55.34

0.75 (1.37%)

06:58
01/18/18
01/18
06:58
01/18/18
06:58
Hot Stocks
Morgan Stanley reports total client assets were $2.4T at Q4-end »

Total client assets were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

GLD

SPDR Gold Trust

$126.14

-1.03 (-0.81%)

06:58
01/18/18
01/18
06:58
01/18/18
06:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$88.98

0.46 (0.52%)

06:57
01/18/18
01/18
06:57
01/18/18
06:57
Hot Stocks
Ryder appoints Rajeev Ravindran Chief Information Officer »

Ryder appointed Rajeev…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

NUGT

Direxion Gold Miners Bull

$34.40

-1.75 (-4.84%)

06:57
01/18/18
01/18
06:57
01/18/18
06:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$55.35

0.75 (1.37%)

06:56
01/18/18
01/18
06:56
01/18/18
06:56
Hot Stocks
Morgan Stanley CEO: We enter 2018 with strong momentum »

James P. Gorman, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.83

-0.99 (-5.00%)

06:56
01/18/18
01/18
06:56
01/18/18
06:56
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$21.38

1.07 (5.27%)

06:55
01/18/18
01/18
06:55
01/18/18
06:55
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$351.01

15.85 (4.73%)

06:55
01/18/18
01/18
06:55
01/18/18
06:55
Periodicals
Lawmakers question safety of SpaceX, Boeing internal helium tanks, WSJ reports »

The National Aeronautics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

MS

Morgan Stanley

$55.34

0.75 (1.37%)

06:55
01/18/18
01/18
06:55
01/18/18
06:55
Earnings
Morgan Stanley reports Q4 EPS 84c, consensus 77c »

Reports Q4 revenue $9.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$46.85

2.29 (5.14%)

06:55
01/18/18
01/18
06:55
01/18/18
06:55
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$26.83

-0.61 (-2.22%)

06:54
01/18/18
01/18
06:54
01/18/18
06:54
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.